|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S1
|
$142,498
|
$8,550
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S2
|
$200,000
|
$12,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
$158,735
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$45,901
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$1,362
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$757
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$30,758
|
Barr, Frederic
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$3,561,926
|
$178,096
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$256,149
|
$128,075
|
Burke, Terrence
|
CCR (NCI)
|
|
Defining the Cellular Oncogenome of Kaposi Sarcoma
|
5R21CA206851-02
|
$171,135
|
$171,135
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
KSHV interactions with host inflammasome components
|
5R01CA180758-06
|
$301,889
|
$301,889
|
CHANDRAN, BALA
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Mechanism and Function of Mitophagy Regulation by HHV-8 Viral Interferon Regulatory Factor-1
|
5R01CA214131-02
|
$374,578
|
$374,578
|
CHOI, YOUNG BONG
|
JOHNS HOPKINS UNIVERSITY
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
5R44CA206788-03
|
$601,993
|
$601,993
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Viral Oncology Training Grant
|
5T32CA009111-40
|
$391,340
|
$39,134
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Role of KSHV Viral Proteins in Signaling and Pathogenesis
|
2R01CA096500-16
|
$314,888
|
$314,888
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
3P01CA019014-39S1
|
$63,936
|
$35,804
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
5P01CA019014-39
|
$1,812,080
|
$1,014,765
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Impact of HIV on the Tumor Microenvironment
|
1R01CA228172-01
|
$466,495
|
$233,248
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
5R01CA163217-08
|
$342,759
|
$171,380
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$6,716
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-20S1
|
$225,000
|
$11,250
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-20S2
|
$248,465
|
$12,423
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-20S3
|
$124,966
|
$6,248
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
5P30CA069533-20
|
$2,310,000
|
$115,500
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016086-42S1
|
$93,750
|
$4,688
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-42S2
|
$249,994
|
$12,500
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-42S3
|
$63,060
|
$3,153
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-42S4
|
$41,000
|
$2,050
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-42S5
|
$89,030
|
$4,452
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
5P30CA016086-42
|
$7,252,540
|
$362,627
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
$196,947
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
HIV and Cancer
|
ZIA CP010150 10071
|
$63,128
|
$18,938
|
Engels, Eric
|
DCEG (NCI)
|
|
Cancer Risk in Solid Organ Transplant Recipients
|
ZIA CP010150 10362
|
$146,079
|
$14,608
|
Engels, Eric
|
DCEG (NCI)
|
|
Early Stage Diagnosis of Kaposis Sarcoma in Limited Resource Settings using KS-Detect
|
4UH3CA202723-03
|
$993,475
|
$993,475
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$2,436
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$376,109
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
NFAT activation in kGPCR tumorigenesis
|
5R01CA221521-02
|
$377,438
|
$377,438
|
FENG, PINGHUI
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant
|
3P30CA047904-30S1
|
$115,192
|
$4,608
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-30S2
|
|
$0
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-30S3
|
$249,783
|
$9,991
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA047904-30
|
$5,129,654
|
$205,186
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cell model for KSHV infection and genetic manipulation
|
5R01CA096512-11
|
|
$0
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Mechanism of KSHV-induced angiogenesis
|
5R01CA132637-10
|
|
$0
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeting KSHV malignancies and persistent infection
|
5R01CA197153-04
|
$19,444
|
$19,444
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cell model for KSHV Infection and Genetic Manipulation
|
7R01CA096512-12
|
$391,250
|
$391,250
|
GAO, SHOU-JIANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Mechanism of KSHV-induced angiogenesis
|
7R01CA132637-11
|
$1
|
$1
|
GAO, SHOU-JIANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Targeting KSHV malignancies and persistent infection
|
7R01CA197153-05
|
$357,994
|
$357,994
|
GAO, SHOU-JIANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA015704-43S1
|
$78,024
|
$1,560
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Kaposi Sarcoma for this search: $29,866,256
|